Newsroom

Sorted by: Latest

-

Xtrackers II UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 15 January 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, an...
-

Wipro Announces Results for the Quarter Ended December 31, 2025

EAST BRUNSWICK, N.J. & BANGALORE, India--(BUSINESS WIRE)--Wipro Limited announced financial results under International Financial Reporting Standards (IFRS) for the quarter ended December 31, 2025....
-

Vaccinium Macrocarpon Extract Industry Research 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Vaccinium Macrocarpon Extract (CAS 91770-88-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Vaccinium macrocarpon extract provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study...
-

Best's Review Looks at What’s Shaping the Insurance Industry’s Future, What’s Being Overlooked

OLDWICK, N.J.--(BUSINESS WIRE)--In its January issue, Best’s Review shares insight from leaders across the insurance spectrum on the topics shaping the industry’s future, including artificial intelligence, talent recruitment, catastrophes, social inflation and nuclear verdicts. Read “Forward Thinking: Executives Discuss AI, Regulation, Secondary Perils” here. In another article, executives from major companies and brokers in the insurance industry share what they believe are the significant iss...
-

Xtrackers UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 15 January 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and t...
-

Deutsche Bank AG UK Regulatory Announcement: Issuance of Securities

LONDON--(BUSINESS WIRE)--  DB ETC PLC Dated: 15 January 2026 COMPANY ANNOUNCEMENT Immediate Release 15 January 2026 DB ETC plc (the Issuer) Law 1991 (as amended) with registered number 103781) Re: Issuance of ETC Securities Announcement The Issuer has agreed to issue ETC Securities for the following Series as set out in the table below. Series Tranche Number of Securities to be issued Trade Date Settlement Date ISIN: Series 04 - Xtrackers Physical Silver EUR Hedged ETC 405 3,900 14 January 2026...
-

Charles Schwab Investment Management, Inc. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions...
-

Naltrexone Hydrochloride (CAS 16676-29-2) Industry Research 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Naltrexone Hydrochloride (CAS 16676-29-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Naltrexone hydrochloride provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as...
-

Colgate-Palmolive Webcasts 2025 Fourth Quarter & Full Year Earnings Conference Call January 30, 2026 – 8:30 a.m. ET

NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate’s website at...
-

Deutsche Bank AG UK Regulatory Announcement: Value per Security

LONDON--(BUSINESS WIRE)--  DB ETC PLC Dated: 16 January 2026 COMPANY ANNOUNCEMENT Immediate Release 16 January 2026 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Value per Security of ETC Securities Announcement The Issuer is providing the Value per Security for the ETC Securities for the following Series as set out in the table below for 15 January 2026 Series ISIN Currency Value per Security...